| TOTHOVÁ, E., Roman HÁJEK, Johannes DRACH, Zdeněk ADAM, B. LABAR, M. EGYED, H. GISSLINGER, I. KUHN, A. HINKE a H. LUDWIG. Thalidomide-dexamethasone vs. melphalan-prednisone as first line treatment and thalidomide-interferon vs. interferon maintenance therapy in elderly patients with multiple myeloma. In Transfuze a hematologie dnes. 2008. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{817700,
author = {Tothová, E. and Hájek, Roman and Drach, Johannes and Adam, Zdeněk and Labar, B. and Egyed, M. and Gisslinger, H. and Kuhn, I. and Hinke, A. and Ludwig, H.},
booktitle = {Transfuze a hematologie dnes},
keywords = {muptiple myeloma},
language = {eng},
title = {Thalidomide-dexamethasone vs. melphalan-prednisone as first line treatment and thalidomide-interferon vs. interferon maintenance therapy in elderly patients with multiple myeloma.},
year = {2008}
}
TY - CONF
ID - 817700
AU - Tothová, E. - Hájek, Roman - Drach, Johannes - Adam, Zdeněk - Labar, B. - Egyed, M. - Gisslinger, H. - Kuhn, I. - Hinke, A. - Ludwig, H.
PY - 2008
TI - Thalidomide-dexamethasone vs. melphalan-prednisone as first line treatment and thalidomide-interferon vs. interferon maintenance therapy in elderly patients with multiple myeloma.
KW - muptiple myeloma
N2 - Thalidomide-dexamethasone vs. melphalan-prednisone as first line treatment and thalidomide-interferon vs. interferon maintenance therapy in elderly patients with multiple myeloma.
ER -
TOTHOVÁ, E., Roman HÁJEK, Johannes DRACH, Zdeněk ADAM, B. LABAR, M. EGYED, H. GISSLINGER, I. KUHN, A. HINKE a H. LUDWIG. Thalidomide-dexamethasone vs. melphalan-prednisone as first line treatment and thalidomide-interferon vs. interferon maintenance therapy in elderly patients with multiple myeloma. In \textit{Transfuze a hematologie dnes}. 2008.
|
